FitBit and coaching app aim to ease CAR-T side effects in landmark trial
NCT ID NCT07186192
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests whether a digital health program—including a FitBit, a mobile app, and nurse coaching—can help 190 people receiving CAR-T therapy and their family caregivers better manage symptoms and distress. Participants will use the tools for 90 days while reporting their symptoms and stress levels. The goal is to see if this approach improves quality of life and reduces the burden of treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- digital health intervention (educational coaching, FitBit, mobile app)
- What this could lead to
- If it works, this could provide a practical way to reduce symptom burden and distress for people undergoing CAR-T therapy and their caregivers.
- What could go wrong
- This is a Phase 3 trial, but it tests a supportive intervention, not a cure. The benefits may be modest and depend on patient engagement with the app and coaching.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91010, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI platform aims to unlock Real-World cancer data on a massive scale
- 10,000 DNA samples could reveal hidden genetic triggers for leukemia and lymphoma
- Could a common arthritis drug shield transplant patients from a dangerous virus?
- New biologic MK-1045 targets Hard-to-Treat blood cancers
- Shorter chemo before transplant may cut severe side effects for blood cancer patients
- Blood test could predict bleeding risk in cancer patients